New Strategies to Reduce HF Readmissions

Slides:



Advertisements
Similar presentations
7A Improving Patient Outcomes by Decreasing Patient Readmission Rates Authors: (Marlena Didonoato) Karen Eggers, 7A staff, Dr Rhode, Donna Mcclish, Deby.
Advertisements

Achieving High-Quality, Low Cost Care Amidst Payment System Reform
From Knowledge to Practice Translation A Multidisciplinary Intervention to Reduce 30 day Heart Failure Readmissions.
SUMMARY OF DATA ASSET INVENTORY QUESTIONNAIRE RESULTS HIT Task Force June 4, 2015 Meeting #2.
Depression As a Predictor of Mortality and Hospitalization Among Hemodialysis Patients in the United States and Europe.
Group 7 Hospital Readmission Predictive Analytics
Tracking Readmissions HomeTown Medicare Meeting
Fundamental Payment Reform for Chronic Care
Perspectives on Managing Polycythemia Vera for the Nurse Practitioner and Physician Assistant.
Emerging Concepts in Heart Failure
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
NOACs for Cancer-Associated Thrombosis:
Optimizing Outcomes in Short Bowel Syndrome With IF
Heart Failure and Hospital Readmissions
Heart Rate, HF Admissions, and Readmissions
A CASE CHALLENGE IN HFrEF:
Addressing Neuropsychiatric Symptoms in Patients With Dementia
Update on Clostridium difficile Infection
Select Topics in Cardiovascular Medicine
Please consider these data to be preliminary until they have been published in peer-reviewed journals.
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Cost Effectiveness and Optimal Outcomes in HF
Addressing Iron Deficiency in Chronic HF
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
Adverse Neurohormonal Activation in HF Has Formed the Basis for Evidence-Based Pharmacologic Therapy
Heart Failure Management Coordinated Care Approaches
Heart Failure Prevention: Mission Impossible?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Improving Management of Type 2 Diabetes in Hispanic/Latino Patients
Identifying and Treating Patients With SBS-IF
Seizures in the Elderly: Treatment and Special Considerations
Advances in the Management of Severe and Life-Threatening Chemotoxicity.
PrEP.
Preventing Heart Failure Readmission and Progression
Antithrombotic Protection in CAD and HF
How to Optimize TAVR Outcomes
Understanding PAD.
Risk Stratification in CAD and PAD
Evaluating New Therapies in HF
Practical Strategies to Reduce HF Hospitalizations in African American Patients.
Using Heart Rate as a Biomarker in Clinical Practice.
Multidisciplinary Management of Hyperkalemia:
Overcoming Clinical Inertia
Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.
Updates in Heart Failure:
Revisiting the Pharmacoeconomics of HF
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy
Program Goals Overview Is NEDA a Reasonable Target?
PAH-Related Morbidity as a Predictor of Mortality
Diabetes Pandemic. The Economics of Managing Patients With Diabetes and Coronary Artery Disease: A Payer Perspective.
Managing HF in Primary Care
Transitional Care of Patients With Hepatic Encephalopathy
Iron Deficiency in Heart Failure
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Program Goals Background: Anticoagulation in Patients With VTE.
Maximizing Organ Protection in Patients With CKD and Comorbidities on RAAS Therapy.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Perspective on the Multidisciplinary Management of PAH
Selecting Treatment Approaches in Hemophilia
2015 EASD In Review: CV Risk management in t2dm
HF-Related Hospitalization and Readmissions
Heart Failure Currently, an estimated 5.7 million Americans are living with heart failure. An additional 670,000 new cases are diagnosed annually, up.
Evaluating the Science of Cardiogenic Shock
Reassessing Risk Stratification in CAD/PAD
Pulmonary Arterial Hypertension and Hospitalizations
In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?
My PAH Patient.
BRIDGING CVD AND T2DM: LESSONS LEARNED FROM OUTCOME TRIALS
Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.
Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.
Presentation transcript:

New Strategies to Reduce HF Readmissions

Goals

Hospitalizations and Healthcare Costs: Need for Reduction in Hospitalizations of Patients With HF

Medicare 30-Day Readmission Penalty

Proportions of Readmissions for Causes Other Than the Condition at Initial Discharge

Hospitalization = Disease Changes

Hospitals Have Financial Incentives

HF: The Natural Trajectory

Comorbidities and HF

A Large Number of Eligible Patients Are Untreated

Risk-Treatment Mismatch in HF

Lack of Symptoms ≠ Stability of the Disease

Prevent Repeat HF Hospitalizations: Predictor of Mortality

PARADIGM-HF

PARADIGM-HF: Outcomes

Additions to the Armamentarium

Multidisciplinary Team Approach

Summary and Take-Away Points

Abbreviations

Abbreviations (cont)